Left Menu
Development News Edition

CORRECTED-GLOBAL MARKETS-Shares, dollar rebound on thaw in U.S.-China trade war

Reuters | Updated: 14-08-2019 05:58 IST | Created: 14-08-2019 05:56 IST
CORRECTED-GLOBAL MARKETS-Shares, dollar rebound on thaw in U.S.-China trade war
Image Credit: Pixabay

U.S. and European stocks jumped, the dollar strengthened and Treasury yields rose on Tuesday after the United States said it would delay tariffs on some Chinese products, easing concerns that a protracted trade war would harm global growth.

President Donald Trump backed off his plan to impose 10% tariffs on Sept. 1 on remaining Chinese imports, delaying duties on cellphones, laptops and many other consumer goods in the hopes of blunting their impact on U.S. holiday sales. Equity, debt and currency markets sharply reversed course minutes after Wall Street opened for trade on news from Hong Kong about a call Chinese Vice Premier Liu He held with U.S. officials, according to China's Commerce Ministry.

Liu spoke with U.S. Trade Representative Robert Lighthizer and U.S. Treasury Secretary Steven Mnuchin on Tuesday evening, a ministry statement said. Shares of Apple Inc, a likely beneficiary of the tariff delay, rose 4.5% and the information technology sector rose 2.46%, the biggest gainer among the 11 S&P 500 sectors.

Investors are closely watching the headlines and that is what markets are trading off of, said Candice Bangsund, a global asset allocation strategist at Fiera Capital in Montreal. "The news today is obviously good news. Risk appetite has improved drastically but it's consistent with the environment of elevated uncertainty," Bangsund said.

Global growth should re-accelerate later this year as major central banks cut interest rates and recent economic data proves better than where markets have traded on it, Bangsund said. The damage created by tariffs will not go away because economic uncertainly remains, said Kristina Hooper, chief global market strategist at Invesco in New York.

"We can continue in the situation we've been in for months which is one step forward, further into the trade war abyss, followed by one step or a half step backwards," Hooper said. Wall Street rallied on news of the tariff delay.

The Dow Jones Industrial Average rose 372.54 points, or 1.44%, to 26,279.91. The S&P 500 gained 42.57 points, or 1.48%, to 2,926.32. The Nasdaq Composite added 152.95 points, or 1.95%, to 8,016.36. Major stock bourses in Europe also surged, with the Euro STOXX index of eurozone shares closing 0.92% higher.

Major equity indices had tumbled roughly 5% since late July on growing concerns that the ongoing U.S.-Chinese trade dispute would slam global growth and fester unresolved until after the November 2020 U.S. presidential election. Markets also had slipped, with gold earlier hitting a more than six-year high, as the unrest in Hong Kong and a rout in the Argentine peso drove investors already rattled by the trade war into havens such as bullion, bonds and the yen.

The yen benefits in moments of geopolitical uncertainty and during economic downturns. The U.S. dollar rose 1.27% to 106.63 yen per dollar. Yields on the benchmark U.S. 10-year Treasury notes hit session highs, while those on 30-year Treasury bonds rallied from more than three-year lows. Traders earlier were bracing for 30-year yields to sink to a record low below 2.08%.

The 10-year Treasury fell 15/32 in price to push its yield up to 1.6949%. Oil prices rose more than 3% on the trade news.

Brent futures settled up $2.73 at $61.30 a barrel, while U.S. West Texas Intermediate (WTI) crude rose $2.17 to settle at $57.10 a barrel. Prior to Tuesday's gains, Brent had traded down more than 20% since hitting a year high in April.

The Argentine peso was less volatile, trading in a tighter range, down 6.04% at 55.30 to the dollar. U.S. gold futures settled down 0.2% to $1,514.1 an ounce.



Pride in the time of coronavirus: a welcome move online?

This year is different in many ways not least as celebrations are also taking place against the dramatic backdrop of a global health crisis and a resurgence in grassroots activism following the death of George Floyd in Minneapolis. ...

COVID-19: Weighing up the benefits and limitations of edtech platforms

Edtech companies shouldnt focus on merely pushing contents, but to provide an interactive, effective teaching and learning environment. ...

Shipping industry's COVID-19 resilience test could boost digitalization

The push towards digitalization in shipping industry was already happening and has been further accelerated by the pandemic as current practices are not tenable under present circumstances and would definitely not be in the future....

Health is pure science but why objectivity eludes WHO

We certainly need a global body to coordinate responses against health emergencies. However, this sheer need of humanity on this planet should not be milked by the World Organization WHO to overshadow constructive criticism and call for ref...


Latest News

Thousands of Greeks protest against bill to regulate demonstrations

Thousands of Greek protesters rallied in central Athens on Thursday against government plans to regulate frequent street demonstrations which often cause disruption in the city. Street protests are the main form of opposition against govern...

Allowing pvt entities in train operations wrong and illogical decision: Former railway ministers

Two former railway ministers on Thursday slammed the Centres decision to allow private entities in passenger train operations, saying it is a reflection of anti-people mindset of the BJP government. They demanded that the Centre reconsider ...

Fire breaks out at Iran's Natanz nuclear facility but operations unaffected, officials say

A fire broke out at Irans Natanz nuclear facility on Thursday but operations were unaffected, officials said, as a former official suggested the incident could have been an attempt to sabotage work breaching an international nuclear deal. T...

Moderna shares slide after report of delay in COVID-19 vaccine trial

Shares of Moderna Inc fell 7 on Thursday after medical news site STAT reported a delay in a large trial testing the biotechs potential coronavirus vaccine as the company makes changes to its study plan. The late-stage trial to test Modernas...

Give Feedback